Sekar Kathiresan
Verve Therapeutics (United States)(US)
Publications by Year
Research Areas
Genetic Associations and Epidemiology, Lipoproteins and Cardiovascular Health, Lipid metabolism and disorders, Atherosclerosis and Cardiovascular Diseases, Diabetes, Cardiovascular Risks, and Lipoproteins
Most-Cited Works
- → Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease(2011)1,937 cited
- → Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease(2016)1,442 cited
- → In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates(2021)725 cited
- → Searching for missing heritability: Designing rare variant association studies(2014)681 cited
- → Genetics of coronary artery disease: discovery, biology and clinical translation(2017)677 cited
- → Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction(2014)676 cited
- → Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants(2022)648 cited
- → Testing for an Unusual Distribution of Rare Variants(2011)598 cited
- → A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses(2010)569 cited
- → Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting(2017)567 cited